Celsense, Inc. to Give Company Presentation at the Cell and Gene Meeting on the Mesa
August 30, 2019 – Pittsburgh, PA
Dr. Eric T. Ahrens, Professor of Radiology at the University of California San Diego and the founder of Celsense, Inc., will give a scientific presentation on Thursday October 3, 2019 at 10:00 a.m. at the 2019 Cell and Gene Meeting on the Mesa in Carlsbad, CA. Dr. Ahrens’s presentation will include new data regarding FETRIS, a second generation MRI cell tracking product.
Organized by the Alliance for Regenerative Medicine (ARM), the 2019 Cell and Gene Meeting on the Mesa is a three-day conference (October 2-4) aimed at bringing together senior members of the advanced therapies industry with the scientific research community to advance cell and gene therapy science into cures.
Held at the Park Hyatt Avianca Resort, this meeting attracts over 1,200 attendees from around the globe, features over 100 speakers, and fosters key partnerships through one-on-one meetings at the Partnering Forum. The Partnering Forum, held October 2-3, is the only partnering meeting organized specifically for the advanced therapies industry.
Please visit https://www.meetingonthemesa.com/ for full information including registration.
Celsense, Inc. develops and offers novel pre-clinical and clinical-grade products that enable the non-invasive imaging of cells in vivo using MRI. The company’s lead product Cell Sense is a patented fluorocarbon tracer agent used to safely and efficiently label cells ex vivo without the use of transfection agents. Cell Sense is the subject of a Drug Master File at US FDA and Health Canada, and is the only clinical grade MRI cell tracking reagent available in North America. Using software developed by Celsense, investigators can quantify the number of labeled cells in a user-specified region of interest. Celsense’s mission is to be the standard for cellular imaging in human health.
Information Contact: Charlie O’Hanlon, President and CEO of Celsense, Inc., (412) 263-2870 or firstname.lastname@example.org
Real-Time Results,<br />Faster and More Accurate
Celsense offers products that enable real-time MRI detection of inflammation and cellular therapeutics. The mission of the company is to be the standard for cellular imaging in human health.
GET IN TOUCH
Send Us A Message
© 2020 Celsense, Inc. All rights reserved.